Image of Gail H Cassell

Gail H Cassell, Ph.D.

Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.

Affiliations:

Division of Global Health Equity, Brigham and Women's Hospital

Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia. Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.

Ureaplasma urealyticum and chronic lung disease of prematurity: critical appraisal of the literature on causation.
Authors: Authors: Wang EE, Cassell GH, Sánchez PJ, Regan JA, Payne NR, Liu PP.
Clin Infect Dis
View full abstract on Pubmed
Microbial invasion of the amniotic cavity during term labor. Prevalence and clinical significance.
Authors: Authors: Romero R, Nores J, Mazor M, Sepulveda W, Oyarzun E, Parra M, Insunza A, Montiel F, Behnke E, Cassell GH.
J Reprod Med
View full abstract on Pubmed
Phylogenetic analysis of Mycoplasma penetrans, isolated from HIV-infected patients.
Authors: Authors: Behbahani N, Blanchard A, Cassell GH, Montagnier L.
FEMS Microbiol Lett
View full abstract on Pubmed
Evaluation of intraspecies genetic variation within the 16S rRNA gene of Mycoplasma hominis and detection by polymerase chain reaction.
Authors: Authors: Blanchard A, Yáñez A, Dybvig K, Watson HL, Griffiths G, Cassell GH.
J Clin Microbiol
View full abstract on Pubmed
Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns.
Authors: Authors: Cassell GH, Waites KB, Watson HL, Crouse DT, Harasawa R.
Clin Microbiol Rev
View full abstract on Pubmed
Biological warfare: role of scientific societies.
Authors: Authors: Cassell GH, Miller LA, Rest RF.
Ann N Y Acad Sci
View full abstract on Pubmed
Septic arthritis and bacteremia due to Mycoplasma resistant to antimicrobial therapy in a patient with systemic lupus erythematosus.
Authors: Authors: Clough W, Cassell GH, Duffy LB, Rinaldi RZ, Bluestone R, Morgan MA, Meyer RD.
Clin Infect Dis
View full abstract on Pubmed
Rapid detection of tetM in Mycoplasma hominis and Ureaplasma urealyticum by PCR: tetM confers resistance to tetracycline but not necessarily to doxycycline.
Authors: Authors: Blanchard A, Crabb DM, Dybvig K, Duffy LB, Cassell GH.
FEMS Microbiol Lett
View full abstract on Pubmed
Serotype diversity and antigen variation among invasive isolates of Ureaplasma urealyticum from neonates.
Authors: Authors: Zheng X, Watson HL, Waites KB, Cassell GH.
Infect Immun
View full abstract on Pubmed
Infection-induced airway fibrosis in two rat strains with differential susceptibility.
Authors: Authors: McIntosh JC, Simecka JW, Ross SE, Davis JK, Miller EJ, Cassell GH.
Infect Immun
View full abstract on Pubmed